Skip to main content
Metagenomi, Inc. logo

Metagenomi, Inc. — Investor Relations & Filings

Ticker · MGX ISIN · US59102M1045 US Professional, scientific and technical activities
Open in API
Filings indexed 124 across all filing types
Latest filing 2026-01-12 Regulatory Filings
Country US United States of America
Listing US MGX

About Metagenomi, Inc.

https://metagenomi.co/

Metagenomi, Inc. is a genetic medicines company that develops curative therapeutics using its proprietary genome editing toolbox. The company's approach is founded on metagenomics, the study of genetic material recovered from natural environments, to discover and engineer novel gene editing systems. Its wholly-owned toolbox is designed to be capable of correcting various types of genetic mutations through site-specific deletion, integration, and correction. Metagenomi leverages high-throughput screening and AI-based cloud computing to expand its portfolio of editing technologies, focusing on disease indications with well-understood biology and clear clinical development pathways.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 12, 2026. It announces a corporate name change from Metagenomi, Inc. to Metagenomi Therapeutics, Inc., effective January 12, 2026, and includes amendments to the company's certificate of incorporation and bylaws. It also references a press release and a corporate presentation furnished as exhibits. There are no financial statements or detailed financial data included. The primary content is an announcement of corporate changes and related disclosures. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories such as management changes, earnings, or capital updates. The document is not a full report like an Annual Report or Interim Report, nor is it a proxy or voting result. Therefore, the classification is RNS with high confidence.
2026-01-12 English
4
Director's Dealing
2025-12-08 English
4
Director's Dealing
2025-12-08 English
4
Director's Dealing
2025-12-08 English
4
Director's Dealing
2025-12-08 English
4
Director's Dealing
2025-12-02 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.